Latest news
07-02-2024 - New £5 Million LifeArc Call For Preclinical Development of Repurposed Drug Candidates for MND
The LifeArc Translational Challenge in MND is a multi-million pound programme that aims to accelerate scientific innovation for people living with motor neuron disease (MND). The challenge aims to address various strategic gaps in the development of therapies for MND and will include multiple calls, funded by LifeArc and other partners, to support research which aims to reduce the diagnostic delay experienced by people with MND, enable those receiving a positive diagnosis to access treatment sooner, and facilitate earlier recruiting to clinical trials to increase the chances of trial success and developing new disease modifying treatments.
[...]